Inspira Technologies OXY B.H.N. (NASDAQ:IINN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution
Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology
Inspira Technologies OXY B.H.N. (NASDAQ:IINN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.